发明名称 RENAL CELL CANCER TREATMENT AGENT
摘要 PROBLEM TO BE SOLVED: To provide a chemotherapy means which exhibits an extremely effective treatment effect to a renal cell cancer.SOLUTION: The renal cell cancer treatment agent includes: one or more kinase inhibitors selected from a group consisting of sorafenib, sunitinib, axitinib, pazopanib, cediranib, tivozanib, dovitinib, imatinib, gefitinib, erlotinib and their salts; and one or more imidazoliquinolines derivatives selected from a group consisting of imiquimod, resiquimod, sotirimod and their salts as active ingredients.
申请公布号 JP2013142059(A) 申请公布日期 2013.07.22
申请号 JP20120001595 申请日期 2012.01.06
申请人 KOCHI UNIV 发明人 KARASHIMA NAO;SHITSUIN TARO
分类号 A61K31/44;A61K31/404;A61K31/4375;A61K31/4439;A61K31/4709;A61K31/4745;A61K31/496;A61K31/506;A61K31/517;A61K31/5377;A61P35/00;A61P35/04;A61P43/00 主分类号 A61K31/44
代理机构 代理人
主权项
地址